Inventor
CHO EUI HWAN
KR15 patents
⚠️ This page may combine multiple inventors who share the name “CHO EUI HWAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAMJIN PHARM CO LTD
13 patentsUS6028195AFeb 22, 2000
Piperazine derivatives and process for the preparation thereof
SAMJIN PHARM CO LTD35 citations90
US6987114B1Jan 17, 2006
Antiviral pyrimidinedione derivatives and process for the preparation thereof
SAMJIN PHARM CO LTD9 citations71
US5922727AJul 13, 1999
Antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
SAMJIN PHARM CO LTD13 citations70
US6683184B2Jan 27, 2004
Piperazine derivatives and process for the preparation thereof
SAMJIN PHARM CO LTD6 citations61
US6274732B1Aug 14, 2001
Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione
SAMJIN PHARM CO LTD3 citations60
US11420963B2Aug 23, 2022
Rebamipide prodrugs, preparation method and use thereof
SAMJIN PHARM CO LTD1 citations58
US10918725B2Feb 16, 2021
Ophthalmic composition comprising rebamipide and method for preparing the same
SAMJIN PHARM CO LTD0 citations57
US11712414B2Aug 1, 2023
Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof
SAMJIN PHARM CO LTD0 citations56
US5747521AMay 5, 1998
N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same
SAMJIN PHARM CO LTD2 citations53
US7230105B2Jun 12, 2007
9-aminoacridine derivatives and process for the preparation thereof
SAMJIN PHARM CO LTD0 citations50
US7851479B2Dec 14, 2010
Use of pyrimidinedione derivative for preventing or treating hepatitis C
SAMJIN PHARM CO LTD1 citations49
US6620936B2Sep 16, 2003
9-aminoacridine derivatives and process for the preparation thereof
SAMJIN PHARM CO LTD0 citations40
US10844062B2Nov 24, 2020
Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof
SAMJIN PHARM CO LTD0 citations37